MedTrace Logo

Biomarkers for Gynecologic Cancer

NCT02178462 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2018-01-31

No results posted yet for this study

Summary

A novel blood metabolic biomarker, AminoIndexTM (gynecological), was developed for gynecological cancers from over 400 Japanese patient's plasma free amino acid profiles (PFAAs) by a rapid and sensitive LC-MS (Liquid Chromatography - Mass Spectrometry), followed by multivariate statistical analyses. However, further studies to assess whether this biomarker demonstrates the same performance characteristics in non-Japanese populations for cancer is yet to be determined.

Conditions

Sponsors & Collaborators

  • Ohio State University

    collaborator OTHER

  • Ajinomoto Co., Inc.

    lead INDUSTRY

Principal Investigators

  • David O'Malley, MD · Ohio State University

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178462 on ClinicalTrials.gov